Headway Secures $100M To Expand to MA/Medicaid Members
Headway’s $100 million Series D funding round was led by Spark Capital and included participation from Thrive Capital, Accel, a16z and Forerunner Ventures. The post
Headway’s $100 million Series D funding round was led by Spark Capital and included participation from Thrive Capital, Accel, a16z and Forerunner Ventures. The post
The good news is that many ACOs have already made the transition to eCQM reporting. Proven best practices are now available. Savvy ACOs will capitalize
Autobahn Therapeutics’ platform technology enables small molecules to selectively hit targets in the brain. In addition to a lead program ready for Phase 2 testing
Access to minimally invasive treatment of complex vascular conditions is still limited worldwide. Bringing endovascular robots to ORs and healthcare facilities worldwide is key to
To bring cross-agency clinical leaders together, the FDA should establish a Center of Excellence for Rare Diseases. This would bring together specialized staff and resources
Vicky Demas, CEO of identifeye Health, talks about the company’s approach to probe the retina with its proprietary device and companion algorithm. The reitna, she
HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.